COVID-19: present and future challenges for dental practice

N Dar-Odeh, H Babkair, S Abu-Hammad… - International journal of …, 2020 - mdpi.com
COVID-19 was declared a pandemic by the World Health Organization, with a high fatality
rate that may reach 8%. The disease is caused by SARS-CoV-2 which is one of the …

SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes

CI Wu, PG Postema, E Arbelo, ER Behr, CR Bezzina… - Heart rhythm, 2020 - Elsevier
Ever since the first case was reported at the end of 2019, the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and the associated coronavirus disease 2019 …

Considerations for drug interactions on QTc in exploratory COVID-19 treatment

DM Roden, RA Harrington, A Poppas, AM Russo - Circulation, 2020 - Am Heart Assoc
1. Chen CY, Wang FL, Lin CC. Chronic hydroxychloroquine use associated with QT
prolongation and refractory ventricular arrhythmia. Clin Toxicol (Phila). 2006; 44: 173–175 …

American College of Rheumatology guidance for the management of rheumatic disease in adult patients during the COVID‐19 pandemic: version 2

TR Mikuls, SR Johnson, L Fraenkel… - Arthritis & …, 2020 - Wiley Online Library
Objective To provide guidance to rheumatology providers on the management of adult
rheumatic disease in the context of the coronavirus disease 2019 (COVID‐19) pandemic …

American College of Rheumatology guidance for the management of rheumatic disease in adult patients during the COVID‐19 pandemic: version 1

TR Mikuls, SR Johnson, L Fraenkel… - Arthritis & …, 2020 - Wiley Online Library
Objective To provide guidance to rheumatology providers on the management of adult
rheumatic disease in the context of the coronavirus disease 2019 (COVID‐19) pandemic …

Macrolides and viral infections: focus on azithromycin in COVID-19 pathology

A Pani, M Lauriola, A Romandini… - International journal of …, 2020 - Elsevier
The emergence of the new COVID-19 virus is proving to be a challenge in seeking effective
therapies. Since the most severe clinical manifestation of COVID-19 appears to be a severe …

HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic: Developed in partnership with …

N Varma, NF Marrouche, L Aguinaga, CM Albert… - EP …, 2021 - academic.oup.com
For copies of this document, please contact the Elsevier Inc. Reprint Department (reprints@
elsevier. com). Permissions: Multiple copies, modification, alteration, enhancement, and/or …

Impact of COVID-19 on the cardiovascular system: a review of available reports

RS Soumya, TG Unni, KG Raghu - Cardiovascular drugs and therapy, 2021 - Springer
The recent emergence of the coronavirus disease 19 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in China is now a global health …

The spectrum of antibiotic prescribing during COVID-19 pandemic: a systematic literature review

SH Al-Hadidi, H Alhussain, H Abdel Hadi… - Microbial Drug …, 2021 - liebertpub.com
Objectives: Over the last decades, there has been a significant increase in antimicrobial
prescribing and consumption associated with the development of patients' adverse events …

[HTML][HTML] Advances in the relationship between coronavirus infection and cardiovascular diseases

M Zhao, M Wang, J Zhang, J Ye, Y Xu, Z Wang… - Biomedicine & …, 2020 - Elsevier
The outbreak of coronavirus disease 2019 (COVID-19) has once again aroused people's
concern about coronavirus. Seven human coronaviruses (HCoVs) have been discovered so …